Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 19, 2008

Circulation. 2008
Published online before print June 19, 2008, doi: 10.1161/CIRCULATIONAHA.107.189624
A more recent version of this article appeared on July 8, 2008
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Correction (v118,pe108)
Right arrow All Versions of this Article:
118/2/e29    most recent
CIRCULATIONAHA.107.189624v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Currier, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Currier, J. S.
Related Collections
Right arrow Primary prevention
Right arrow Secondary prevention
Right arrow Other etiology
Right arrow Other Treatment
Right arrow Epidemiology

Submitted on ,
Accepted on ,

Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy

Judith S. Currier MD, Co-Chair, Jens E. Lundgren MD, PhD, Co-Chair, Andrew Carr MD, Daniel Klein MD, Caroline A. Sabin PhD, Paul E. Sax MD, Jeffrey T. Schouten MD, Marek Smieja MD, PhD, for Working Group 2


Key words: AHA Conference Proceedings • AIDS • HIV • myocardial infarction • antiretroviral therapy • protease inhibitors




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. M. Gatell
When and why to start antiretroviral therapy?
J. Antimicrob. Chemother., March 1, 2010; 65(3): 383 - 385.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. M. Mannucci, R. E. G. Schutgens, E. Santagostino, and E. P. Mauser-Bunschoten
How I treat age-related morbidities in elderly persons with hemophilia
Blood, December 17, 2009; 114(26): 5256 - 5263.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
M. Rotger, C. Bayard, P. Taffe, R. Martinez, M. Cavassini, E. Bernasconi, M. Battegay, B. Hirschel, H. Furrer, A. Witteck, et al.
Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study
Circ Cardiovasc Genet, December 1, 2009; 2(6): 621 - 628.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E Hulten, J Mitchell, J Scally, B Gibbs, and T C Villines
HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies
Heart, November 15, 2009; 95(22): 1826 - 1835.
[Abstract] [Full Text] [PDF]


Home page
Menopause IntHome page
M. D Fan, B.-S. Maslow, N. Santoro, and E. Schoenbaum
HIV and the menopause
Menopause Int, December 1, 2008; 14(4): 163 - 168.
[Abstract] [Full Text] [PDF]